{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:03:12Z","timestamp":1759334592010,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011324","name":"Qingdao University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jfo.2022.09.024","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T18:04:06Z","timestamp":1676397846000},"page":"239-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of the reports of low-concentration atropine in controlling myopia in children"],"prefix":"10.1016","volume":"46","author":[{"given":"M.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2022.09.024_bib0140","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.ophtha.2010.01.020","article-title":"Prevalence and progression of myopic retinopathy in Chinese adults: the Beijing Eye Study","volume":"117","author":"Liu","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2022.09.024_bib0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ophtha.2015.07.002","article-title":"The association of refractive error with glaucoma in a multiethnic population","volume":"123","author":"Shen","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2022.09.024_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/APO.0000000000000169","article-title":"Refractive error and the risk of age-related macular degeneration in the south korean population","volume":"5","author":"Lin","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.jfo.2022.09.024_bib0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","article-title":"Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review","volume":"157","author":"Wong","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.024_bib0160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/APO.0000000000000256","article-title":"Low-concentration atropine eye drops for myopia progression","volume":"8","author":"Li","year":"2019","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"year":"2021","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6. 2 (updated February 2021)","author":"Higgins","key":"10.1016\/j.jfo.2022.09.024_bib0165"},{"key":"10.1016\/j.jfo.2022.09.024_bib0170","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jfo.2022.09.024_bib0175","first-page":"494","article-title":"Effect of 0.01% atropine eye drops on the development of myopia in school-age children [J]","volume":"38","author":"Rong","year":"2020","journal-title":"Chinese J Experiment Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.024_bib0180","doi-asserted-by":"crossref","first-page":"A124","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2022.09.024_bib0185","first-page":"533","article-title":"et all. The effect of 0.01% atropine eye drops in controlling myopia in adolescents and its influence on accommodation function[J]","volume":"28","author":"Zheng","year":"2020","journal-title":"J Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.024_bib0190","first-page":"102","article-title":"Analysis of the effectiveness of 0.01% atropine in controlling myopia progression[J]","volume":"39","author":"Meng","year":"2020","journal-title":"Chinese and Foreign Medical"},{"key":"10.1016\/j.jfo.2022.09.024_bib0195","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in chinese children: a randomized clinical trial","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.024_bib0200","first-page":"1139","article-title":"Observation on the efficacy of 0.01% atropine preparations in controlling myopia in children[J]","volume":"49","author":"Shen","year":"2020","journal-title":"Shanxi Medical Journal"},{"key":"10.1016\/j.jfo.2022.09.024_bib0205","first-page":"89","article-title":"Analysis of the efficacy of 0.01% atropine in controlling myopia in adolescents[J]","volume":"49","author":"Liu","year":"2020","journal-title":"Shanxi Medical Journal"},{"key":"10.1016\/j.jfo.2022.09.024_bib0210","first-page":"73","article-title":"The World Bank Publishes Gender Data Manual [J]","volume":"32","author":"Bai","year":"2019","journal-title":"World Education Information"},{"key":"10.1016\/j.jfo.2022.09.024_bib0215","first-page":"54","article-title":"The latest announcement of the ratio of males and females in 31 provinces [J]","volume":"36","author":"Zichu","year":"2021","journal-title":"Branch Construction"},{"key":"10.1016\/j.jfo.2022.09.024_bib0220","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1475-1313.1999.00438.x","article-title":"Prevention of form-deprivation myopia with pirenzepine: a study of drug delivery and distribution","volume":"19","author":"Cottriall","year":"1999","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.jfo.2022.09.024_bib0225","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1167\/iovs.12-9943","article-title":"Muscarinic antagonist control of myopia: evidence for M4 and M1 receptor-based pathways in the inhibition of experimentally-induced axial myopia in the tree shrew","volume":"53","author":"Arumugam","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2022.09.024_bib0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0952523800171184","article-title":"Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick","volume":"17","author":"Schwahn","year":"2000","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.jfo.2022.09.024_bib0235","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10384-018-0608-3","article-title":"Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results","volume":"62","author":"Kinoshita","year":"2018","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.024_bib0240","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2022.09.024_bib0245","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.18240\/ijo.2019.08.16","article-title":"Atropine 0.01% eye drops slow myopia progression: a systematic review and Meta-analysis","volume":"12","author":"Zhao","year":"2019","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.024_bib0250","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1111\/aos.14166","article-title":"Efficacy of atropine 0.01% for the treatment of childhood myopia in European patients","volume":"97","author":"Sacchi","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.024_bib0255","doi-asserted-by":"crossref","first-page":"17344","DOI":"10.1038\/s41598-021-96698-6","article-title":"Stepwise low concentration atropine for myopic control: a 10-year cohort study","volume":"11","author":"Chuang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfo.2022.09.024_bib0260","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12886-020-01746-w","article-title":"Efficacy and safety of atropine to control myopia progression: a systematic review and meta-analysis","volume":"20","author":"Zhao","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jfo.2022.09.024_bib0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2022.09.024_bib0270","first-page":"299","article-title":"Comparison of 0.5% cyclopentolate plus 0.5% tropicamide and 1% cyclopentolate alone for mydriasis of dark irides","volume":"23","author":"Nishizawa","year":"1988","journal-title":"Can J Ophthalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223000281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551223000281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:19:38Z","timestamp":1759259978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551223000281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0181551223000281"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2022.09.024","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the reports of low-concentration atropine in controlling myopia in children","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2022.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}